a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Clinical trial NCT06718270 · RECRUITING

Trial details

NCT number: NCT06718270
Sponsor: Shanghai Changzheng Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Plasma Cell Leukemia

Start date: 2024-12-11
Primary completion: 2027-01-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.